WORTHING MEDICAL GROUP
23 SHELLEY ROAD, WORTHING
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 483 | 597 | 80.9% | |
| CKD 4 | 2008 | 519 | 591 | 87.8% | |
| CKD 5 | 2009 | 162 | 186 | 87.1% | |
| CKD 5 | 2010 | 75 | 77 | 97.4% | |
| CKD 5 | 2011 | 72 | 74 | 97.3% | |
| CKD 5 | 2012 | 64 | 72 | 88.9% | |
| CKD 5 | 2013 | 55 | 59 | 93.2% | |
| CKD003 | 2014 | 51 | 54 | 94.4% | |
| CKD003 | 2015 | 48 | 50 | 96.0% | |
| NM84 | 2017 | 40 | 78 | 51.3% | |
| NM84 | 2018 | 42 | 80 | 52.5% | |
| NM84 | 2019 | 36 | 61 | 59.0% | |
| NM84 | 2020 | 29 | 61 | 47.5% | |
| NM84 | 2022 | 36 | 64 | 56.2% | |
| NM84 | 2023 | 34 | 61 | 55.7% |
